|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-6-8
|
|
pubmed:abstractText |
Pegylated liposomal doxorubicin (PLD, CAELYX) has demonstrated activity in several phase-III trials and has been approved for the therapy of relapsed ovarian cancer after platinum treatment. Aim of this observational study was to analyze the efficacy and toxicity profile of PLD under routine clinical conditions and without the general restrictions of defined inclusion and exclusion criteria of clinical trials.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1432-0843
|
|
pubmed:author |
pubmed-author:CamaraOO,
pubmed-author:HühnerSS,
pubmed-author:Lorenz-SchlüterCC,
pubmed-author:North-Eastern German Society of Gynecological Oncology,
pubmed-author:Oskay-OzcelikGG,
pubmed-author:OtrembaBB,
pubmed-author:SchmalfeldtBB,
pubmed-author:SchmidtMM,
pubmed-author:SehouliJalidJ,
pubmed-author:SeipeltGG,
pubmed-author:TeschHH
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
64
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
585-91
|
|
pubmed:meshHeading |
pubmed-meshheading:19156414-Adult,
pubmed-meshheading:19156414-Aged,
pubmed-meshheading:19156414-Aged, 80 and over,
pubmed-meshheading:19156414-Antibiotics, Antineoplastic,
pubmed-meshheading:19156414-Disease-Free Survival,
pubmed-meshheading:19156414-Dose-Response Relationship, Drug,
pubmed-meshheading:19156414-Doxorubicin,
pubmed-meshheading:19156414-Female,
pubmed-meshheading:19156414-Germany,
pubmed-meshheading:19156414-Humans,
pubmed-meshheading:19156414-Middle Aged,
pubmed-meshheading:19156414-Neoplasm Recurrence, Local,
pubmed-meshheading:19156414-Ovarian Neoplasms,
pubmed-meshheading:19156414-Polyethylene Glycols,
pubmed-meshheading:19156414-Remission Induction,
pubmed-meshheading:19156414-Survival Rate,
pubmed-meshheading:19156414-Treatment Outcome,
pubmed-meshheading:19156414-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Pegylated liposomal doxorubicin (CAELYX) in patients with advanced ovarian cancer: results of a German multicenter observational study.
|
|
pubmed:affiliation |
Department of Gynecology and Obstetrics, Charité Campus Virchow-Klinikum, University Medicine Berlin, Berlin, Germany. sehouli@aol.com
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|
